Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11410717rdf:typepubmed:Citationlld:pubmed
pubmed-article:11410717lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C0000966lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C0048504lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C1412335lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:11410717lifeskim:mentionsumls-concept:C0442040lld:lifeskim
pubmed-article:11410717pubmed:issue6lld:pubmed
pubmed-article:11410717pubmed:dateCreated2001-6-18lld:pubmed
pubmed-article:11410717pubmed:abstractTextCarcinogenic acetaldehyde is produced from ethanol locally in the upper digestive tract via alcohol dehydrogenases (ADHs) of oral microbes, mucosal cells, and salivary glands. Acetaldehyde is further oxidized into less harmful acetate mainly by the aldehyde dehydrogenase-2 (ALDH2) enzyme. ALDH2-deficiency increases salivary acetaldehyde levels and the risk for upper digestive tract cancer in heavy alcohol drinkers. 4-methylpyrazole (4-MP) is an ADH-inhibitor which could reduce the local production of acetaldehyde from ethanol in the saliva.lld:pubmed
pubmed-article:11410717pubmed:languageenglld:pubmed
pubmed-article:11410717pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11410717pubmed:citationSubsetIMlld:pubmed
pubmed-article:11410717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11410717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11410717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11410717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11410717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11410717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11410717pubmed:statusMEDLINElld:pubmed
pubmed-article:11410717pubmed:monthJunlld:pubmed
pubmed-article:11410717pubmed:issn0145-6008lld:pubmed
pubmed-article:11410717pubmed:authorpubmed-author:SalaspuroMMlld:pubmed
pubmed-article:11410717pubmed:authorpubmed-author:VäkeväinenSSlld:pubmed
pubmed-article:11410717pubmed:authorpubmed-author:TillonenJJlld:pubmed
pubmed-article:11410717pubmed:issnTypePrintlld:pubmed
pubmed-article:11410717pubmed:volume25lld:pubmed
pubmed-article:11410717pubmed:ownerNLMlld:pubmed
pubmed-article:11410717pubmed:authorsCompleteYlld:pubmed
pubmed-article:11410717pubmed:pagination829-34lld:pubmed
pubmed-article:11410717pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:meshHeadingpubmed-meshheading:11410717...lld:pubmed
pubmed-article:11410717pubmed:year2001lld:pubmed
pubmed-article:11410717pubmed:articleTitle4-Methylpyrazole decreases salivary acetaldehyde levels in aldh2-deficient subjects but not in subjects with normal aldh2.lld:pubmed
pubmed-article:11410717pubmed:affiliationResearch Unit of Alcohol Diseases, Helsinki University Central Hospital, Helsinki, Finland.lld:pubmed
pubmed-article:11410717pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11410717pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11410717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11410717lld:pubmed